Reference 2017-360

REF:            2017-360

Subject:        Ocriplasmin (Jetrea) treatment for vitreo-macular traction




We are working on a project to improve expenditure in eye departments. We are trying to understand the cost effectiveness of Ocriplasmin (Jetrea) treatment for vitreo-macular traction.

We would like to obtain data regarding the number of injections performed, and possibly cost, of this treatment in your Trust, should you have ever provided it.

The time frame would be 01/01/2016 to 31/05/2017, if possible divided by month; otherwise just a total number will suffice.

Would you be able to assist? We would be most grateful for your help. An electronic response via email to this address will be much appreciated.




We have not used any Ocriplasmin injections between 01/01/2016 and 31/05/2017.